Literature DB >> 26179882

Blimp-1 homolog Hobit identifies effector-type lymphocytes in humans.

Felipe A Vieira Braga1, Kirsten M L Hertoghs2, Natasja A M Kragten1,2, Gina M Doody3, Nicholas A Barnes3, Ester B M Remmerswaal2,4, Cheng-Chih Hsiao2, Perry D Moerland5, Diana Wouters1, Ingrid A M Derks2, Amber van Stijn2,4, Marc Demkes2, Jörg Hamann2, Eric Eldering2, Martijn A Nolte1,2, Reuben M Tooze3, Ineke J M ten Berge4, Klaas P J M van Gisbergen1,2, René A W van Lier1,2.   

Abstract

Human cytomegalovirus (CMV) induces the formation of effector CD8(+) T cells that are maintained for decades during the latent stage of infection. Effector CD8(+) T cells appear quiescent, but maintain constitutive cytolytic capacity and can immediately produce inflammatory cytokines such as IFN-γ after stimulation. It is unclear how effector CD8(+) T cells can be constitutively maintained in a terminal stage of effector differentiation in the absence of overt viral replication. We have recently described the zinc finger protein Homolog of Blimp-1 in T cells (Hobit) in murine NKT cells. Here, we show that human Hobit was uniformly expressed in effector-type CD8(+) T cells, but not in naive or in most memory CD8(+) T cells. Human CMV-specific but not influenza-specific CD8(+) T cells expressed high levels of Hobit. Consistent with the high homology between the DNA-binding Zinc Finger domains of Hobit and Blimp-1, Hobit displayed transcriptional activity at Blimp-1 target sites. Expression of Hobit strongly correlated with T-bet and IFN-γ expression within the CD8(+) T-cell population. Furthermore, Hobit was both necessary and sufficient for the production of IFN-γ. These data implicate Hobit as a novel transcriptional regulator in quiescent human effector-type CD8(+) T cells that regulates their immediate effector functions.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CD8 T cells; NK cells; Transcription factors

Mesh:

Substances:

Year:  2015        PMID: 26179882     DOI: 10.1002/eji.201545650

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  47 in total

1.  CD29 identifies IFN-γ-producing human CD8+ T cells with an increased cytotoxic potential.

Authors:  Benoît P Nicolet; Aurélie Guislain; Floris P J van Alphen; Raquel Gomez-Eerland; Ton N M Schumacher; Maartje van den Biggelaar; Monika C Wolkers
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-11       Impact factor: 11.205

2.  Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells.

Authors:  Pleun Hombrink; Christina Helbig; Ronald A Backer; Berber Piet; Anna E Oja; Regina Stark; Giso Brasser; Aldo Jongejan; René E Jonkers; Benjamin Nota; Onur Basak; Hans C Clevers; Perry D Moerland; Derk Amsen; René A W van Lier
Journal:  Nat Immunol       Date:  2016-10-24       Impact factor: 25.606

Review 3.  Tissue-Specific Control of Tissue-Resident Memory T Cells.

Authors:  Yong Liu; Chaoyu Ma; Nu Zhang
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

4.  Trigger-happy resident memory CD4+ T cells inhabit the human lungs.

Authors:  A E Oja; B Piet; C Helbig; R Stark; D van der Zwan; H Blaauwgeers; E B M Remmerswaal; D Amsen; R E Jonkers; P D Moerland; M A Nolte; R A W van Lier; P Hombrink
Journal:  Mucosal Immunol       Date:  2017-11-15       Impact factor: 7.313

5.  Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy.

Authors:  Yong-Chen Lu; Li Jia; Zhili Zheng; Eric Tran; Paul F Robbins; Steven A Rosenberg
Journal:  Cancer Immunol Res       Date:  2019-09-04       Impact factor: 11.151

6.  Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis.

Authors:  Veena S Patil; Ariel Madrigal; Benjamin J Schmiedel; James Clarke; Patrick O'Rourke; Aruna D de Silva; Eva Harris; Bjoern Peters; Gregory Seumois; Daniela Weiskopf; Alessandro Sette; Pandurangan Vijayanand
Journal:  Sci Immunol       Date:  2018-01-19

7.  The checkpoint for agonist selection precedes conventional selection in human thymus.

Authors:  Greet Verstichel; David Vermijlen; Liesbet Martens; Glenn Goetgeluk; Margreet Brouwer; Nicolas Thiault; Yasmine Van Caeneghem; Stijn De Munter; Karin Weening; Sarah Bonte; Georges Leclercq; Tom Taghon; Tessa Kerre; Yvan Saeys; Jo Van Dorpe; Hilde Cheroutre; Bart Vandekerckhove
Journal:  Sci Immunol       Date:  2017-02-24

Review 8.  Human T Cell Development, Localization, and Function throughout Life.

Authors:  Brahma V Kumar; Thomas J Connors; Donna L Farber
Journal:  Immunity       Date:  2018-02-20       Impact factor: 31.745

9.  Distinct Gene Regulatory Pathways for Human Innate versus Adaptive Lymphoid Cells.

Authors:  Olivia I Koues; Patrick L Collins; Marina Cella; Michelle L Robinette; Sofia I Porter; Sarah C Pyfrom; Jacqueline E Payton; Marco Colonna; Eugene M Oltz
Journal:  Cell       Date:  2016-05-05       Impact factor: 41.582

Review 10.  Programmed T cell differentiation: Implications for transplantation.

Authors:  Rebecca L Crepeau; Mandy L Ford
Journal:  Cell Immunol       Date:  2020-03-29       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.